Lumibird

LUMIBIRD PRESENTS ITS NEW STRATEGIC PLAN

22 май 2024 11:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE

03 май 2024 01:30:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: PUBLICATION OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT INCLUDING THE ANNUAL FINANCIAL REPORT

05 апр 2024 11:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2024

25 мар 2024 12:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: ANNUAL RESULTS 2023

12 мар 2024 12:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR CV90

29 фев 2024 11:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: 2023 REVENUES AT €203.6M

29 янв 2024 11:46:50 Источник Nasdaq GlobeNewswire

LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA

26 янв 2024 10:10:00 Источник Nasdaq GlobeNewswire

LUMIBIRD ADJUSTS ITS 2023 GROWTH TARGET

14 дек 2023 11:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD CLARIFIES ITS INTENTIONS REGARDING CILAS

24 ноя 2023 02:00:00 Источник Nasdaq GlobeNewswire

LUMIBIRD : QUANTEL MEDICAL ONE OF THE FIRST WINNERS OF THE FRANCE 2030 “MEDICAL IMAGING” CALL FOR PROJECTS

15 ноя 2023 11:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: REVENUES FOR THE FIRST 9 MONTHS OF 2023: €139.0M (+11%)

24 окт 2023 11:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: 2023 HALF-YEAR EARNINGS

26 сен 2023 11:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: MAJOR CONTRACT SIGNED FOR LASER RANGEFINDERS FOR DEFENCE APPLICATIONS

14 сен 2023 11:35:00 Источник Nasdaq GlobeNewswire

LUMIBIRD COMPLETES ACQUISITION OF PRIMA INDUSTRIE'S HIGH POWER LASER AND SEMICONDUCTOR BUSINESSES IN ITALY AND THE UNITED STATES

31 авг 2023 11:35:00 Источник Nasdaq GlobeNewswire

Lumibird announces agreement to acquire Prima Industrie's high power laser and semiconductor businesses

16 май 2023 01:30:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: 8% GROWTH FOR THE FIRST QUARTER OF 2023

24 апр 2023 11:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD RECEIVES MARKETING APPROVAL IN CHINA FOR ITS VITRA 2 PHOTOCOAGULATOR

17 апр 2023 11:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 28, 2023

24 мар 2023 12:45:00 Источник Nasdaq GlobeNewswire

LUMIBIRD: FY 2022 RESULTS

14 мар 2023 12:50:00 Источник Nasdaq GlobeNewswire